Health score, price, valuation, risk signals, and key metrics at a glance.
Grade capped at D — Interest coverage below 1× (0.1x) — earnings cannot cover interest. Strongest: Cash & Earnings Quality (15/25); weakest: Balance Sheet & Red Flags (3/25).
Today's multiple positioned against its own trailing range — a visual premium/discount check.
Currently above its 16-quarter median.
Currently near its 20-quarter median.
Data-driven signals worth keeping an eye on across the last 8 quarters
Operating margins dropped 204.3% over recent quarters — a sharp decline suggesting serious cost or pricing challenges.
FCF consistently trails net income (avg -6.0x) — earnings may be inflated by non-cash items or aggressive accounting.
as of June 2026
Revenue, EBITDA, operating income, net income, EPS, and shares
Gross, EBITDA, operating, and net margin trends
P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield
Total assets, cash, debt, book value, and leverage
Operating cash flow, free cash flow, FCF margin, and earnings quality
Currently near its 20-quarter median.
D/E ratio is 16.7 — heavily leveraged and vulnerable to rising rates or cash flow dips.
TTM revenue has contracted 25.3% — significant decline indicating deteriorating demand.
FCF turned negative in 2 of the last 8 quarters — occasional cash consumption.